2018

Bhatt et al. reported on the very successful REDUCE-IT trial at the American Heart Association Scientific Sessions. In this study, 4 g/d of EPA reduced CVD endpoints by 25% in patients on statins. This was a major development in the omega-3 story and stated the fact that one has to take a high enough dose of omega-3 to get its benefits.